Search
Displaying 461–470 of 578 for “Retinitis pigmentosa”
-
Foundation Fighting Blindness Announces Leadership Changes
Foundation NewsJason Menzo named chief executive officer • Russell Kelley, PhD, MBA, appointed managing director of the RD Fund • Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company.
-
Foundation Fighting Blindness to Host VISIONS 2022 Conference
Foundation NewsThe national conference will be held on June 17–18, featuring sessions with the latest research advancements, practical adapting and thriving, and an opportunity to connect with the blind and low vision community.
-
Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer
Foundation NewsNoteworthy Foundation executive increases role within organization.
-
In the Press
Initial programs will focus on treatments for rare pediatric blinding conditions. Company formed to advance the work of scientific cofounders Dr. Jean Bennett, Junwei Sun and Dr. Eric Pierce.
-
Our new 2021 PSA campaign, “Together, We’re Winning,” showcases how four individuals living with vision loss continue to ‘win’ on their own terms, by living rich and full lives every day. Lachi, Beverley, Fai, and Mark are all active members of the Foundation Fighting Blindness community and Lulie’s Next Chapter network, and each maintains a positive attitude and winning spirit.
-
Pediatric Ophthalmologists Target Inherited Retinal Diseases
In the PressNew opportunities continue to develop in an evolving landscape.
-
Foundation News
Course Title: Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities
-
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
In the PressFormer Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna™, to lead development of SparingVision’s proprietary asset, SPVN06, and further pipeline development
-
Foundation News
Mr. Ginsberg brings twenty-five years of rare disease corporate development, finance, strategy, and investment leadership experience.
-
Virtual Workshop on Inflammation in Viral Gene Therapy of the Retina
This workshop was designed to bring together industry and academia to discuss openly what is known about the interactions of viral-mediated gene therapy of the retina with the immune system and the clinical consequences of that.
